The FDA announced today that it has issued another emergency use authorization (EUA) for a second COVID booster vaccine for adults over the age of 50, and as young as 12 years old if they are "immune compromised." Pfizer had made the request for a second booster shot two weeks ago, but their request was for adults over the age of 65. The FDA, however, lowered that to age 50, and issued the EUA for both the Pfizer and Moderna COVID-19 vaccines. Do you think the FDA looked at the data in their Vaccine Adverse Event Reporting System (VAERS) regarding COVID-19 vaccines for this age group to see if there were any concerns before authorizing a second booster shot for this age group? Not likely. As we have previously reported, the FDA does no safety oversight on these vaccines, but simply takes the drug manufacturers' word for it, allowing them to police themselves. So we will review the data on this age group in VAERS as a service to the public.